Safety study of an injection for people with obesity or overweight
Part of Hormones & metabolism clinical trials.
This study tests a new injection called ASC36 in people who are overweight or have obesity, to see if it is safe, how the body processes it, and what effects it has. It may help with weight loss, but the main goal is safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are a non-smoker.
- Your BMI is 27 or higher (overweight or obesity).
- You are generally healthy, without serious active or chronic diseases.
- If you are a woman, you must not be pregnant, breastfeeding, or planning to become pregnant, and you must use effective birth control if needed.
- You have not used any weight-loss prescription or investigational drugs in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an injectable medication called ASC35 to see if it is safe and tolerable for people who are overweight or obese. It may help with weight management, though it is an early-stage trial focused on safety first.
This study is testing an oral tablet (ASC36) to see if it is safe and how well it works for weight loss in adults who are overweight or have obesity. It is a first-in-human trial, so researchers are also studying how the body absorbs and processes the drug.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This trial tests a new injection called SA030 to see if it can help with weight loss in people who are overweight or obese. It's an early-stage study, so the main goals are to check safety and how the body handles the drug.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
Hear when a new Chronic Weight Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.